These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22443460)

  • 41. Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting.
    Xanthopoulou I; Davlouros P; Tsigkas G; Panagiotou A; Hahalis G; Alexopoulos D
    Can J Cardiol; 2011; 27(6):716-24. PubMed ID: 22019279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison.
    Ijsselmuiden AJ; Ezechiels J; Westendorp IC; Tijssen JG; Kiemeneij F; Slagboom T; van der Wieken R; Tangelder G; Serruys PW; Laarman G
    Am Heart J; 2004 Sep; 148(3):467-74. PubMed ID: 15389234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
    J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention.
    Nuttall GA; Brown MJ; Stombaugh JW; Michon PB; Hathaway MF; Lindeen KC; Hanson AC; Schroeder DR; Oliver WC; Holmes DR; Rihal CS
    Anesthesiology; 2008 Oct; 109(4):588-95. PubMed ID: 18813036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
    Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW
    J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE Registry).
    Caggegi A; Capodanno D; Capranzano P; Chisari A; Ministeri M; Mangiameli A; Ronsivalle G; Ricca G; Barrano G; Monaco S; Di Salvo ME; Tamburino C
    Am J Cardiol; 2011 Aug; 108(3):355-9. PubMed ID: 21545992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site.
    Mauri L; Normand SL; Pencina M; Cutlip DE; Jeon C; Dreyer P; Kuntz RE; Baim DS; Jacobs AK
    Am Heart J; 2011 Nov; 162(5):826-31. PubMed ID: 22093197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction.
    Corpus RA; House JA; Marso SP; Grantham JA; Huber KC; Laster SB; Johnson WL; Daniels WC; Barth CW; Giorgi LV; Rutherford BD
    Am Heart J; 2004 Sep; 148(3):493-500. PubMed ID: 15389238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of interventionalist volume, experience, and board certification on coronary angioplasty outcomes in the era of stenting.
    Harjai KJ; Berman AD; Grines CL; Kahn J; Marsalese D; Mehta RH; Schreiber T; Boura JA; O'Neill WW
    Am J Cardiol; 2004 Aug; 94(4):421-6. PubMed ID: 15325922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of on-site cardiac catheterization on resource utilization and fatal and non-fatal outcomes after acute myocardial infarction.
    Halabi AR; Beck CA; Eisenberg MJ; Richard H; Pilote L
    BMC Health Serv Res; 2006 Nov; 6():148. PubMed ID: 17096849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonprimary PCI at hospitals without cardiac surgery on-site: Consistent outcomes for all?
    Czarny MJ; Miller JM; Naiman DQ; Hwang CW; Hasan RK; Lemmon CC; Aversano T
    Am Heart J; 2018 Mar; 197():18-26. PubMed ID: 29447780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.
    Aversano T; Aversano LT; Passamani E; Knatterud GL; Terrin ML; Williams DO; Forman SA;
    JAMA; 2002 Apr; 287(15):1943-51. PubMed ID: 11960536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous coronary intervention without onsite cardiac surgery.
    Sørensen LL; Kjøller-Hansen L; Jensen GV; Poulsen B; Fisker D; Carstensen S
    Dan Med Bull; 2010 Nov; 57(11):A4202. PubMed ID: 21055368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience.
    Singh M; Gersh BJ; Lennon RJ; Ting HH; Holmes DR; Doyle BJ; Rihal CS
    Mayo Clin Proc; 2009 Jun; 84(6):501-8. PubMed ID: 19483166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The long-term effect of premier pay for performance on patient outcomes.
    Jha AK; Joynt KE; Orav EJ; Epstein AM
    N Engl J Med; 2012 Apr; 366(17):1606-15. PubMed ID: 22455751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes of nonemergent percutaneous coronary intervention with and without on-site surgical backup: a meta-analysis.
    Singh PP; Singh M; Bedi US; Adigopula S; Singh S; Kodumuri V; Molnar J; Ahmed A; Arora R; Khosla S
    Am J Ther; 2011; 18(2):e22-8. PubMed ID: 19918168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Percutaneous coronary intervention with vs without on-site cardiac surgery backup: a systematic review and meta-analysis.
    Zia MI; Wijeysundera HC; Tu JV; Lee DS; Ko DT
    Can J Cardiol; 2011; 27(5):664.e9-16. PubMed ID: 21546209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.